Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Chimerix stock

Learn how to easily invest in Chimerix stock.

Chimerix is a biotechnology business based in the US. Chimerix shares (CMRX) are listed on the NASDAQ and all prices are listed in US Dollars. Chimerix employs 87 staff and has a trailing 12-month revenue of around $33.1 million.

How to buy Chimerix stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – CMRX. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award

eToro


  • Easy to use platform with low fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100

Promoted for easy user experience

Robinhood


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Chimerix stock price (NASDAQ: CMRX)

Use our graph to track the performance of CMRX stocks over time.

Chimerix shares at a glance

Information last updated 2023-02-02.
Latest market close$1.82
52-week range$1.27 - $6.43
50-day moving average $1.98
200-day moving average $2.29
Wall St. target price$7.50
PE ratio 1.0643
Dividend yield $0 (0%)
Earnings per share (TTM) $1.71

Buy Chimerix stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
eToro
Stocks, Options, ETFs, Cryptocurrency
$0
$10
FINDER EXCLUSIVE: Get $15
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Chimerix stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Chimerix price performance over time

Historical closes compared with the close of $1.82 from 2023-02-03

1 week (2023-01-31) 2.82%
1 month (2023-01-06) -2.67%
3 months (2022-11-07) -6.19%
6 months (2022-08-05) -32.09%
1 year (2022-02-03) N/A
2 years (2021-02-05) -81.31%
3 years (2020-02-07) 7.69%
5 years (2018-02-07) 4.93

Is Chimerix stock undervalued or overvalued?

Valuing Chimerix stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Chimerix's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Chimerix's P/E ratio

Chimerix's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, Chimerix shares trade at around 1x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Chimerix financials

Revenue TTM $33.1 million
Gross profit TTM $-71,838,000
Return on assets TTM -22.26%
Return on equity TTM 81.17%
Profit margin 464.75%
Book value $3.11
Market capitalisation $160.2 million

TTM: trailing 12 months

Chimerix share dividends

We're not expecting Chimerix to pay a dividend over the next 12 months.

Chimerix share price volatility

Over the last 12 months, Chimerix's shares have ranged in value from as little as $1.27 up to $6.43. A popular way to gauge a stock's volatility is its "beta".

CMRX.US volatility(beta: 1.18)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Chimerix's is 1.1821. This would suggest that Chimerix's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Chimerix overview

Chimerix, Inc. , a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs include ONC201 a program for treating tumors which harbor the H3 K27M mutation in recurrent diffuse midline glioma patients; ONC206, an imipridone, Dopamine Receptor D2 (DRD2) antagonist, and caseinolytic protease P (ClpP) agonist that demonstrated enhanced non-competitive DRD2 antagonism relative to ONC201, which is in Phase I clinical trials to treat solid tumors; ONC212, an imipridone agonist of the orphan G protein-coupled receptors (GPCR) tumor suppressor GPR132, as well as ClpP for solid tumors and hematological malignancies, including pancreatic cancer and leukemias; and dociparstat sodium (DSTAT), which inhibits the activities of key proteins implicated in the resistance of acute myeloid leukemia blasts and leukemic stem cells to chemotherapy. The company has license agreements with Biomedical Advanced Research and Development Authority for the development of brincidofovir for use in the treatment of smallpox; Cantex Pharmaceuticals, Inc. to develop and commercialize a glycosaminoglycan compound; and SymBio Pharmaceuticals to develop, manufacture, and commercialize BCV for various human indications. Chimerix, Inc.

Frequently asked questions

What percentage of Chimerix is owned by insiders or institutions?
Currently 9.982% of Chimerix shares are held by insiders and 63.097% by institutions.
How many people work for Chimerix?
Latest data suggests 87 work at Chimerix.
When does the fiscal year end for Chimerix?
Chimerix's fiscal year ends in December.
Where is Chimerix based?
Chimerix's address is: 2505 Meridian Parkway, Durham, NC, United States, 27713
What is Chimerix's ISIN number?
Chimerix's international securities identification number is: US16934W1062
What is Chimerix's CUSIP number?
Chimerix's Committee on Uniform Securities Identification Procedures number is: 16934W106

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site